Oncology Society of New Jersey Members/Colleagues
On Wednesday, May 5th, 2010, the Oncology Society of New Jersey will host a scientific forum devoted to Clinical Cancer Research in New Jersey. We invite you to submit abstracts of current clinical research and/or case reports on topics relevant to hematology and oncology. Read More >>

Resident Program Directors
On Wednesday, May 5th, 2010, the Oncology Society of New Jersey will host a scientific forum devoted to Clinical Cancer Research in New Jersey. We hereby invite interested residents and fellows to submit abstracts of current clinical research projects and/or case reports on topics relevant to hematology and oncology. Read More >>

Save the Date

Friday, April 23, 2010

The John Theurer Cancer Center at Hackensack University Medical Center

presents

Current and Innovative Modalities in the Management of Hematologic Malignancies
6.5 AMA PRA Category 1 Credit™ Available

Program Features:

Multiple Myeloma: A Changing Landscape
Ken Anderson, MD • Dana Farber Cancer Center

Non-Myeloablative Transplants: Expanding the Field, New Strategies to Improve Outcome
Frederick R. Appelbaum, MD • Fred Hutchinson Cancer Research Center

Diffuse Large Cell Lymphoma: Can We Stratify Patients Beyond the R-CHOP Era?
James Armitage, MD • University of Nebraska Medical Center

Indolent Lymphomas: Changing Perspectives;
What is the Best Sequence Among All Options Available?
Thomas Witzig, MD • Mayo Clinic

Hodgkin Lymphoma: ABVD Does Not Fit All
Volker Diehl, MD • German Hodgkin Study Group – University of Cologne

T-cell Lymphomas: Still a Very Challenging Disease
Steven Rosen, MD • Robert H. Lurie Comprehensive Cancer Center

Acute Myeloid Leukemias: The Impact of Molecular Stratification
Martin Tallman, MD • Robert H. Lurie Comprehensive Cancer Center

Adjusting to the Changing Environment of Health Care
Kip Piper, MA, FACHE, President Health Results Group, LLC

Purpose: This program is designed to provide physicians with a review of current and innovative patient care options, novel therapies through clinical trials and emerging concepts in the management of hematological malignancies.

Objectives: At the conclusion of this learning activity the participant will be able to:

• Review the biology of large cell lymphoma and its impact on treatment approaches

• Recognize the new prognostic markers (beyond FLIPI) and new approaches in low grade lymphoma

• Examine new classification in T-cell lymphoma and emerging strategies

• Improve treatment / stratification of patients with early versus advanced stage Hodgkin Disease

• Introduce more advance use of PET scans in lymphomas and its use for managing patients

• Identify the changes in the management of multiple myeloma

• Appreciate emerging molecular stratification of acute myeloid leukemia

Credit: Hackensack University Medical Center is accredited by the Medical Society of New Jersey to sponsor continuing medical education for physicians. Hackensack University Medical Center designates this educational activity for 6.5 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Cost: Registration, breakfast and lunch are complimentary.

Date: Friday, April 23, 2010

Time: 8:00 AM – 4:30 PM

Place: John Theurer Cancer Center at Hackensack University Medical Center
The Hekemian Conference Center Auditorium, 30 Prospect Avenue, Hackensack, NJ

To register please contact Laura Long, 201-996-3663, LLong@humed.com